Abstract:Background: Cytoskeleton-associated protein 2-like protein (CKAP2L) is thought to promote the progression of glioma, breast cancer, and ovarian cancer. However, the role of cytoskeleton-associated protein 2-like protein in clear cell renal cell carcinoma (ccRCC) is still unclear. The study aimed to investigate the roles and mechanisms of cytoskeleton-associated protein 2-like protein in clear cell renal cell carcinoma. Methods: The level of cytoskeleton-associated protein 2-like protein in tumors was explored by using UALCAN and Oncomine databases. Gene expression datasets of clear cell renal cell carcinoma from The Cancer Genome Atlas and Gene Expression Omnibus (GEO) were also used to validate the cytoskeleton-associated protein 2-like protein level in clear cell renal cell carcinoma. Survival analysis was performed to investigate the relationship between cytoskeleton-associated protein 2-like protein level and prognosis of clear cell renal cell carcinoma patients. Cox regression analysis was used for identifying the independent prognostic factors. Gene set enrichment analysis (GSEA), gene set variation analysis (GSVA), protein–protein interaction analysis, co-expression analysis, and immune infiltration analysis were used to explore the potential mechanisms of cytoskeleton-associated protein 2-like protein in clear cell renal cell carcinoma. Moreover, the levels of cytoskeleton-associated protein 2-like protein in clinical clear cell renal cell carcinoma tissues were also measured using RT-PCR, immunohistochemical analysis, and Western blotting. M1 macrophages and CD4 + T cells were also detected by immunohistochemistry between tumor and normal tissues. Results: The level of cytoskeleton-associated protein 2-like protein was upregulated in clear cell renal cell carcinoma according to multiple databases and experimental verification. Upregulated cytoskeleton-associated protein 2-like protein is an independent prognostic factor, which might activate the JAK–STAT signaling pathway, the P53 signaling pathway, the TGF-β signaling pathway, the WNT signaling pathway, etc. , in clear cell renal cell carcinoma. Protein–protein interaction analysis and co-expression analysis suggest that cytoskeleton-associated protein 2-like protein might interact with some proliferation proteins. Immune infiltration analysis indicates that cytoskeleton-associated protein 2-like protein may affect the level of activated CD4 + memory T cells, M1 macrophages, CD8 + T cells, and neutrophils in clear cell renal cell carcinoma. More M1 macrophage infiltrations in tumor tissues with higher cytoskeleton-associated protein 2-like protein were validated by clear cell renal cell carcinoma tumor tissues. Conclusion: Cytoskeleton-associated protein 2-like protein is upregulated in clear cell renal cell carcinoma tissues, which may promote progression of the disease. Cytoskeleton-associated protein 2-like protein is a potential target for prognostic markers and a potential treatment target in clear cell renal cell carcinoma.

Significance of PYK2 Level As a Prognosis Predictor in Patients with Colon Adenocarcinoma after Surgical Resection

[Expression of Proline-Rich Tyrosine Kinase-2 in Human Primary Colorectal Carcinoma and Its Prognostic Implication].

Proline-rich Tyrosine Kinase 2 and Its Phosphorylated Form Py881 Are Novel Prognostic Markers for Non-Small-cell Lung Cancer Progression and Patients’ Overall Survival

High Expression of Proline-Rich Tyrosine Kinase2 is Associated with Poor Survival of Hepatocellular Carcinoma Via Regulating Phosphatidylinositol 3-Kinase/akt Pathway

[Expression of Proline-Rich Tyrosine Kinase-2 (pyk2) in Gastric Carcinoma and Its Significance].

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma

Up-regulated CKS2 Promotes Tumor Progression and Predicts a Poor Prognosis in Human Colorectal Cancer.

Expression and Clinical Significance of CKS2 in Colorectal Cancer

CKS2 Overexpression Correlates with Prognosis and Immune Cell Infiltration in Lung Adenocarcinoma: A Comprehensive Study Based on Bioinformatics and Experiments

Increased Level of Phosphorylation-Annexin A2 is Associated with Higher Tumor Stage and Poor Prognosis in Colorectal Adenocarcinomas

PKM2 Upregulation Promotes Malignancy and Indicates Poor Prognosis for Intrahepatic Cholangiocarcinoma.

High expression of SHP2 predicts a promising prognosis in colorectal cancer

Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.

PKM2 is a Potential Prognostic Biomarker and Related to Immune Infiltration in Lung Cancer

Clinical Significance of ERK Phosphorylation in Locally Advanced Colon Carcinoma

TYK2 Protein Expression and Its Potential as a Tissue-Based Biomarker for the Diagnosis of Colorectal Cancer

Pyrroline-5-Carboxylate Reductase-2 as a Potential Prognostic Biomarker of Colorectal Cancer: A Study Based on Bioinformatics Approaches

Pyruvate Kinase Type M2 is Upregulated in Colorectal Cancer and Promotes Proliferation and Migration of Colon Cancer Cells.

Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma

The Expression Profiles and Clinical Significance of PKM2 and Notch1 in Colorectal Cancer

Identification of CPT2 As a Prognostic Biomarker by Integrating the Metabolism-Associated Gene Signature in Colorectal Cancer